An October recall of COVID-19 antigen tests made by Ellume has been designated by the US Food and Drug Administration as high-risk class I.
The company recalled 2,212,335 of the home tests because there’s a chance they can give false-positive results. The FDA has received 35 reports of false positives, but no deaths have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?